194 related articles for article (PubMed ID: 32484793)
1. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.
Huang KM; Leblanc AF; Uddin ME; Kim JY; Chen M; Eisenmann ED; Gibson AA; Li Y; Hong KW; DiGiacomo D; Xia SH; Alberti P; Chiorazzi A; Housley SN; Cope TC; Sprowl JA; Wang J; Loprinzi CL; Noonan A; Lustberg MB; Cavaletti G; Pabla N; Hu S; Sparreboom A
J Clin Invest; 2020 Sep; 130(9):4601-4606. PubMed ID: 32484793
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
Sprowl JA; Ciarimboli G; Lancaster CS; Giovinazzo H; Gibson AA; Du G; Janke LJ; Cavaletti G; Shields AF; Sparreboom A
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11199-204. PubMed ID: 23776246
[TBL] [Abstract][Full Text] [Related]
3. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
Yi Y; Li L; Song F; Li P; Chen M; Ni S; Zhang H; Zhou H; Zeng S; Jiang H
Toxicology; 2021 Jul; 459():152853. PubMed ID: 34252480
[TBL] [Abstract][Full Text] [Related]
4. Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells.
Buß I; Hamacher A; Sarin N; Kassack MU; Kalayda GV
Metallomics; 2018 Mar; 10(3):414-425. PubMed ID: 29417972
[TBL] [Abstract][Full Text] [Related]
5. Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Nepal MR; Taheri H; Li Y; Talebi Z; Uddin ME; Jin Y; DiGiacomo DF; Gibson AA; Lustberg MB; Hu S; Sparreboom A
Cancer Res Commun; 2022 Nov; 2(11):1334-1343. PubMed ID: 36506732
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the chemotherapeutic agent oxaliplatin and the tyrosine kinase inhibitor dasatinib with the organic cation transporter 2.
Ahmed Eltayeb S; Dressler JM; Schlatt L; Pernecker M; Neugebauer U; Karst U; Ciarimboli G
Arch Toxicol; 2024 Jul; 98(7):2131-2142. PubMed ID: 38589558
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights.
Marmiroli P; Riva B; Pozzi E; Ballarini E; Lim D; Chiorazzi A; Meregalli C; Distasi C; Renn CL; Semperboni S; Morosi L; Ruffinatti FA; Zucchetti M; Dorsey SG; Cavaletti G; Genazzani A; Carozzi VA
PLoS One; 2017; 12(10):e0186250. PubMed ID: 29020118
[TBL] [Abstract][Full Text] [Related]
8. Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin.
Hucke A; Schröter R; Ceresa C; Chiorazzi A; Canta A; Semperboni S; Marmiroli P; Cavaletti G; Gess B; Ciarimboli G
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511245
[TBL] [Abstract][Full Text] [Related]
9. Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity.
Di Cesare Mannelli L; Pacini A; Corti F; Boccella S; Luongo L; Esposito E; Cuzzocrea S; Maione S; Calignano A; Ghelardini C
PLoS One; 2015; 10(6):e0128080. PubMed ID: 26039098
[TBL] [Abstract][Full Text] [Related]
10. An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection.
Hucke A; Rinschen MM; Bauer OB; Sperling M; Karst U; Köppen C; Sommer K; Schröter R; Ceresa C; Chiorazzi A; Canta A; Semperboni S; Marmiroli P; Cavaletti G; Schlatt S; Schlatter E; Pavenstädt H; Heitplatz B; Van Marck V; Sparreboom A; Barz V; Knief A; Deuster D; Zehnhoff-Dinnesen AA; Ciarimboli G
Arch Toxicol; 2019 Oct; 93(10):2835-2848. PubMed ID: 31493026
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
12. Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma.
Chiu CF; Park JM; Chen HH; Mau CZ; Chen PS; Su YH; Chen HA; Liu YR; Hsieh TH; Chiu CC; Hung SW; Kuo CY; Chen YM; Chang CF
Biomed Pharmacother; 2022 Sep; 153():113520. PubMed ID: 36076515
[TBL] [Abstract][Full Text] [Related]
13. Mitigation of cell apoptosis induced by ochratoxin A (OTA) is possibly through organic cation transport 2 (OCT2) knockout.
Qi X; Zhu L; Yang B; Luo H; Xu W; He X; Huang K
Food Chem Toxicol; 2018 Nov; 121():15-23. PubMed ID: 30120945
[TBL] [Abstract][Full Text] [Related]
14. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
Liu Y; Zheng X; Yu Q; Wang H; Tan F; Zhu Q; Yuan L; Jiang H; Yu L; Zeng S
Sci Transl Med; 2016 Jul; 8(348):348ra97. PubMed ID: 27440728
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.
Le Roy B; Tixier L; Pereira B; Sauvanet P; Buc E; Pétorin C; Déchelotte P; Pezet D; Balayssac D
PLoS One; 2016; 11(2):e0148739. PubMed ID: 26859833
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical characterization of mouse dorsal root ganglion neurons expressing organic cation transporter 2.
Matsui T; Nakata T; Kurohmaru M; Kobayashi Y
Neuroreport; 2020 Feb; 31(3):274-280. PubMed ID: 32032285
[TBL] [Abstract][Full Text] [Related]
18. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
19. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity.
Cavaletti G; Ceresa C; Nicolini G; Marmiroli P
Anticancer Res; 2014 Jan; 34(1):483-6. PubMed ID: 24403505
[TBL] [Abstract][Full Text] [Related]
20. Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity.
Yan F; Liu JJ; Ip V; Jamieson SM; McKeage MJ
J Neurochem; 2015 Dec; 135(6):1099-112. PubMed ID: 26364854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
